Selectis HealthGBCS -3.33%45 Net Margin % is 89.53% as of Mar. 2026. GuruFocus rates GBCS with a GF Score™ of 45/100 and a GF Value™ of $2.14 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Selectis Health ranks better than 89.67% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Selectis Health's Net Income for the
three
months ended in Mar. 2026 was $6.53 Mil. Selectis Health's Revenue for the
three
months ended in Mar. 2026 was $7.29 Mil. Therefore, Selectis Health's net margin for the quarter that ended in Mar. 2026 was 89.53%.
The historical rank and industry rank for Selectis Health's Net Margin % or its related term are showing as below:
GBCS'
s Net Margin % Range Over the Past 10 Years
Min: -95.75 Med: -9.7 Max: 16.12
Current: 16.12
GBCS's Net Margin % is ranked better than 89.67% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs GBCS: 16.12
Selectis Health (OTCPK:GBCS) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Selectis Health Net Margin % Related Terms
Selectis Health Net Margin % Historical Data
* Premium members only.
The historical data trend for Selectis Health's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Selectis Health's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selectis Health Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Selectis Health's Net Margin % distribution charts can be found below:
* The bar in red indicates where Selectis Health's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selectis Health (GBCS) has a Net Margin % of 89.53% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Selectis Health and its competitors. According to the industry distribution chart, Selectis Health ranks #69 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 10.3%.
Is Selectis Health's Net Margin % too high?
Selectis Health's current Net Margin % is 89.53%. The Healthcare Providers & Services industry median Net Margin % is 2.89. Selectis Health's value of 89.53% is 3003.3% above this industry median. Based on the distribution chart, Selectis Health ranks #69 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Selectis Health has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selectis Health's Net Margin % compare to AMS and BICX?
According to the Healthcare Providers & Services industry distribution chart, Selectis Health ranks #69 out of 668 companies for Net Margin %. This places Selectis Health in the top 10% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.89. Selectis Health's value of 89.53% is 3003.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Selectis Health's current Net Margin % of 89.53% is 3003.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Selectis Health and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selectis Health's current Net Margin % is 89.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selectis Health stock overvalued right now?
Based on GuruFocus' analysis, Selectis Health (GBCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.14, compared to a current price of $5.22 — trading 143.9% above its estimated fair value. The current Net Margin % is 89.53% and 3003.3% above the Healthcare Providers & Services industry median of 2.89. Selectis Health's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Selectis Health (GBCS), the current Net Margin % is 89.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selectis Health (GBCS) Overvalued in 2026?
Based on GuruFocus' analysis, Selectis Health stock appears to be overvalued.
The current stock price of $5.22 is trading 143.9% above its estimated GF Value™ of $2.14.
GuruFocus considers Selectis Health to be Significantly Overvalued.
Key valuation signals for GBCS:
Net Margin %: 89.53%
GF Value™: $2.14 vs. price of $5.22 (143.9% above fair value)
Industry Position: 3003.3% above the Healthcare Providers & Services median (#69 of 668)
No single metric tells the full story. See the GBCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selectis Health Inc owns and operates medical care facilities in the healthcare industry. The company acquires, develops, leases, and manages healthcare real estate and provides healthcare operations through its wholly-owned subsidiaries. The portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. It makes investments within the healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008, which represents investments in senior housing operations, and (vi) owning healthcare operations.
45GF Score
Get the complete analysis for GBCS
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GBCS has been successfully added to your 
